mRNex® Vaccinia Capping System
An enzyme-based post-transcriptional RNA capping system for generating Cap1-modified mRNA.
Complete capping reagents
Cap0 option
RUO
Product overview
mRNex® Vaccinia Capping System. An enzyme-based post-transcriptional RNA capping system for generating Cap1-modified mRNA.
Cap1 formation
Combines vaccinia capping enzyme and 2′-O-methyltransferase.
Complete capping reagents
Includes buffer, GTP, SAM and RNase inhibitor.
Cap0 option
Omit 2′-O-methyltransferase when Cap0 RNA is required.
Specifications
| Parameter | Value |
|---|---|
| Application | Post-transcriptional RNA capping |
| Reference RNA input | 10 µg |
| Reported reaction duration | Generally within 30 min; RNA-dependent |
| Storage | −25 to −15°C, 1 year. |
| Intended use | Research use only |
Pack sizes & ordering
| Catalog No. | Pack size |
|---|---|
| LD301007 | 50 T |
| LD301007 | 100 T |
| LD301007 | 500 T |
Source: LD301007_mRNex® Vaccinia Capping System_17121ES.pdf, pp. 2–4.
Performance & validation
Combines vaccinia capping enzyme and 2′-O-methyltransferase. Includes buffer, GTP, SAM and RNase inhibitor. Omit 2′-O-methyltransferase when Cap0 RNA is required. Source: LD301007 handbook/CoA, pp. 2–4.
Cap1 formation
Combines vaccinia capping enzyme and 2′-O-methyltransferase.
Complete capping reagents
Includes buffer, GTP, SAM and RNase inhibitor.
Cap0 option
Omit 2′-O-methyltransferase when Cap0 RNA is required.
Product documents
Product FAQs
An enzyme-based post-transcriptional RNA capping system for generating Cap1-modified mRNA. No. The handbook states that the RNA 5′ sequence, secondary structure, length and reaction volume affect the reaction. −25 to −15°C, 1 year. No. It is for research use only.What is this product used for?
Is capping efficiency the same for every RNA?
How should the product be stored?
Is this product intended for diagnostic or clinical use?